Tag: Alzheimers

This week, John Vandermosten, Zacks’ Senior Biotech Analyst, speaks with CEO of ProMIS Neurosciences, Dr. Elliot Goldstein on CEO Money. ProMIS’ ticker is PMN on the Toronto Exchange and ARFXF here in the US. ProMIS is focused on finding a cure for A ...
John VandermostenSenior Biotechnology AnalystZacks Small Cap Researchhttp://scr.zacks.com2017 Biotech/Pharma Year in ReviewLooking at healthcare overall, probably the biggest news of 2017 was related to the attempted repeal of the Affordabl ...
2 / 2 POSTS